Table 1.
GII.3 | GII.4 | |||
---|---|---|---|---|
Serum | BT501 | 50% neutralization2 | BT501 | 50% neutralization2 |
1 | 187 | 990 | 671 | 105,000 |
2 | 70 | 835 | 53 | 214 |
BT50 – Serum titer that blocks the interaction of HuNoV VLPs with H type 1 and H type 3 and porcine gastric mucin glycans by 50%.
50% neutralization – Serum titer that reduces the infectivity of indicated HuNoV strains by 50%.